Home › BIO Launches Survey on FDA/Sponsor Interactions During Drug Development
 

Keywords :   


BIO Launches Survey on FDA/Sponsor Interactions During Drug Development

2014-08-06 06:00:00| Industrial Newsroom - All News for Today

BIO announced survey tool on FDA/Sponsor Interactions During Drug Development to better inform policy initiatives designed to improve FDA and drug sponsor coordination and communication during drug development. Survey will serve to inform next reauthorization of the Prescription Drug User Fee Act VI. By helping to identify areas where policies, regulations, and practices are working well and areas that need improvement, sponsor input will make process more efficient and effective. This story is related to the following:Trade Associations

Tags: development survey drug bio

Category:Industrial Goods and Services

Latest from this category

All news
18.06A Request From the A League of Their Own Womens Special Interest Group
18.06Next MANAchat Series is Scheduled for the Week of August 5
17.06New Federal Government Filing Requirement Regarding Ownership of LLCs and Corporations
17.06Manufacturers Reps That Sell to International Customers June 26 Networking Event
17.06Avoid $591 Daily Penalty From the U.S. Treasury Department
Industrial Goods and Services »
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
More »